Efficacy of hyperthermic isolated limb perfusion in the treatment of locally recurrent high-grade soft tissue sarcoma of the extremities

Abstract Background This novel study compared the use of tumor necrosis factor (TNF)-alpha and melphalan-based isolated limb perfusion (TM-ILP) to the standard treatment of locally recurrent soft tissue extremity sarcoma. The aim was to assess whether TM-ILP positively influences the recurrence-free...

Full description

Bibliographic Details
Main Authors: Farhad Farzaliyev, Alexander Touma, Georg Taeger, Hans-Ulrich Steinau, Jendrik Hardes, Arne Streitbürger, Lars Erik Podleska
Format: Article
Language:English
Published: BMC 2020-12-01
Series:World Journal of Surgical Oncology
Online Access:https://doi.org/10.1186/s12957-020-02110-4
id doaj-b166ddbd1af046359a2fae0be23dd747
record_format Article
spelling doaj-b166ddbd1af046359a2fae0be23dd7472020-12-27T12:09:04ZengBMCWorld Journal of Surgical Oncology1477-78192020-12-011811710.1186/s12957-020-02110-4Efficacy of hyperthermic isolated limb perfusion in the treatment of locally recurrent high-grade soft tissue sarcoma of the extremitiesFarhad Farzaliyev0Alexander Touma1Georg Taeger2Hans-Ulrich Steinau3Jendrik Hardes4Arne Streitbürger5Lars Erik Podleska6Department of General, Visceral and Transplantation Surgery, Division of Plastic and Reconstructive Surgery, University Hospital Essen, University Essen-DuisburgDepartment of General, Visceral and Transplantation Surgery, Division of Plastic and Reconstructive Surgery, University Hospital Essen, University Essen-DuisburgDepartment of Tumor Orthopedics and Sarcoma Surgery, University Hospital EssenDepartment of General, Visceral and Transplantation Surgery, Division of Plastic and Reconstructive Surgery, University Hospital Essen, University Essen-DuisburgDepartment of Tumor Orthopedics and Sarcoma Surgery, University Hospital EssenDepartment of Tumor Orthopedics and Sarcoma Surgery, University Hospital EssenDepartment of Tumor Orthopedics and Sarcoma Surgery, University Hospital EssenAbstract Background This novel study compared the use of tumor necrosis factor (TNF)-alpha and melphalan-based isolated limb perfusion (TM-ILP) to the standard treatment of locally recurrent soft tissue extremity sarcoma. The aim was to assess whether TM-ILP positively influences the recurrence-free survival of locally recurrent high-grade soft tissue sarcoma (STS) of the extremities. Methods We retrospectively analyzed our clinical database for patients with STS. Variables were analyzed using chi-square test or Mann-Whitney rank-sum test. Furthermore, Kaplan-Meier survival plots were calculated and a proportional hazard regression model was developed. Results Out of 448 patients with extraabdominal STS treated between August 2012 and December 2015, 52 cases involving 47 patients had locally recurrent STS. Twenty-eight of these patients were treated with TM-ILP prior to surgical resection (TM-ILP-group), and 24 were treated with standard therapy (without TM-ILP). The 3-year recurrence-free survival for the TM-ILP-group was estimated at 75% (95% confidence interval (CI), 71.5–78.5). Local recurrence-free survival in the standard group was significantly lower (LRFS: 43.4%, 95% CI 38.7–48.1, p = 0.026). Multivariable analysis revealed resection with negative margins, lower number of previous recurrences, and TM-ILP as positive predictors for recurrence-free survival. Conclusions TM-ILP and consecutive resection of residual tumor with negative resection margins significantly improves local recurrence-free survival for patients with a first local recurrence of high-grade STS in the extremities.https://doi.org/10.1186/s12957-020-02110-4
collection DOAJ
language English
format Article
sources DOAJ
author Farhad Farzaliyev
Alexander Touma
Georg Taeger
Hans-Ulrich Steinau
Jendrik Hardes
Arne Streitbürger
Lars Erik Podleska
spellingShingle Farhad Farzaliyev
Alexander Touma
Georg Taeger
Hans-Ulrich Steinau
Jendrik Hardes
Arne Streitbürger
Lars Erik Podleska
Efficacy of hyperthermic isolated limb perfusion in the treatment of locally recurrent high-grade soft tissue sarcoma of the extremities
World Journal of Surgical Oncology
author_facet Farhad Farzaliyev
Alexander Touma
Georg Taeger
Hans-Ulrich Steinau
Jendrik Hardes
Arne Streitbürger
Lars Erik Podleska
author_sort Farhad Farzaliyev
title Efficacy of hyperthermic isolated limb perfusion in the treatment of locally recurrent high-grade soft tissue sarcoma of the extremities
title_short Efficacy of hyperthermic isolated limb perfusion in the treatment of locally recurrent high-grade soft tissue sarcoma of the extremities
title_full Efficacy of hyperthermic isolated limb perfusion in the treatment of locally recurrent high-grade soft tissue sarcoma of the extremities
title_fullStr Efficacy of hyperthermic isolated limb perfusion in the treatment of locally recurrent high-grade soft tissue sarcoma of the extremities
title_full_unstemmed Efficacy of hyperthermic isolated limb perfusion in the treatment of locally recurrent high-grade soft tissue sarcoma of the extremities
title_sort efficacy of hyperthermic isolated limb perfusion in the treatment of locally recurrent high-grade soft tissue sarcoma of the extremities
publisher BMC
series World Journal of Surgical Oncology
issn 1477-7819
publishDate 2020-12-01
description Abstract Background This novel study compared the use of tumor necrosis factor (TNF)-alpha and melphalan-based isolated limb perfusion (TM-ILP) to the standard treatment of locally recurrent soft tissue extremity sarcoma. The aim was to assess whether TM-ILP positively influences the recurrence-free survival of locally recurrent high-grade soft tissue sarcoma (STS) of the extremities. Methods We retrospectively analyzed our clinical database for patients with STS. Variables were analyzed using chi-square test or Mann-Whitney rank-sum test. Furthermore, Kaplan-Meier survival plots were calculated and a proportional hazard regression model was developed. Results Out of 448 patients with extraabdominal STS treated between August 2012 and December 2015, 52 cases involving 47 patients had locally recurrent STS. Twenty-eight of these patients were treated with TM-ILP prior to surgical resection (TM-ILP-group), and 24 were treated with standard therapy (without TM-ILP). The 3-year recurrence-free survival for the TM-ILP-group was estimated at 75% (95% confidence interval (CI), 71.5–78.5). Local recurrence-free survival in the standard group was significantly lower (LRFS: 43.4%, 95% CI 38.7–48.1, p = 0.026). Multivariable analysis revealed resection with negative margins, lower number of previous recurrences, and TM-ILP as positive predictors for recurrence-free survival. Conclusions TM-ILP and consecutive resection of residual tumor with negative resection margins significantly improves local recurrence-free survival for patients with a first local recurrence of high-grade STS in the extremities.
url https://doi.org/10.1186/s12957-020-02110-4
work_keys_str_mv AT farhadfarzaliyev efficacyofhyperthermicisolatedlimbperfusioninthetreatmentoflocallyrecurrenthighgradesofttissuesarcomaoftheextremities
AT alexandertouma efficacyofhyperthermicisolatedlimbperfusioninthetreatmentoflocallyrecurrenthighgradesofttissuesarcomaoftheextremities
AT georgtaeger efficacyofhyperthermicisolatedlimbperfusioninthetreatmentoflocallyrecurrenthighgradesofttissuesarcomaoftheextremities
AT hansulrichsteinau efficacyofhyperthermicisolatedlimbperfusioninthetreatmentoflocallyrecurrenthighgradesofttissuesarcomaoftheextremities
AT jendrikhardes efficacyofhyperthermicisolatedlimbperfusioninthetreatmentoflocallyrecurrenthighgradesofttissuesarcomaoftheextremities
AT arnestreitburger efficacyofhyperthermicisolatedlimbperfusioninthetreatmentoflocallyrecurrenthighgradesofttissuesarcomaoftheextremities
AT larserikpodleska efficacyofhyperthermicisolatedlimbperfusioninthetreatmentoflocallyrecurrenthighgradesofttissuesarcomaoftheextremities
_version_ 1724369321008824320